MA35610B1 - Composition pharmaceutique pour traiter l'éjaculation prématurée et procédé pour traiter l'éjaculation prématurée - Google Patents
Composition pharmaceutique pour traiter l'éjaculation prématurée et procédé pour traiter l'éjaculation prématuréeInfo
- Publication number
- MA35610B1 MA35610B1 MA36706A MA36706A MA35610B1 MA 35610 B1 MA35610 B1 MA 35610B1 MA 36706 A MA36706 A MA 36706A MA 36706 A MA36706 A MA 36706A MA 35610 B1 MA35610 B1 MA 35610B1
- Authority
- MA
- Morocco
- Prior art keywords
- premature ejaculation
- pharmaceutical composition
- treating premature
- present
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne une composition pharmaceutique qui peut être prise avant d'avoir un rapport sexuel selon le besoin de façon à traiter, prévenir ou améliorer l'éjaculation prématurée, et qui comprend 14 à 16 mg de clomipramine hcl, et, de préférence, environ 15 mg, en tant que principe actif. De manière davantage préférée, la composition de la présente invention comprend en outre : de l'amidon prégélatinisé ; et du glycolate d'amidon sodique. La composition pharmaceutique de la présente invention présente rapidement des effets, possède une faible variation de dissolution (absorption) provoquée en raison de la différence des niveaux de ph des tractus gastro-intestinaux des patients, et a des effets secondaires très faibles.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20110062620 | 2011-06-28 | ||
PCT/KR2012/005134 WO2013002578A2 (fr) | 2011-06-28 | 2012-06-28 | Composition pharmaceutique pour traiter l'éjaculation prématurée et procédé pour traiter l'éjaculation prématurée |
Publications (1)
Publication Number | Publication Date |
---|---|
MA35610B1 true MA35610B1 (fr) | 2014-11-01 |
Family
ID=47424682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA36706A MA35610B1 (fr) | 2011-06-28 | 2014-01-22 | Composition pharmaceutique pour traiter l'éjaculation prématurée et procédé pour traiter l'éjaculation prématurée |
Country Status (20)
Country | Link |
---|---|
US (2) | US20140200210A1 (fr) |
EP (2) | EP2727595B1 (fr) |
JP (1) | JP6042886B2 (fr) |
KR (1) | KR101978459B1 (fr) |
CN (1) | CN103635194B (fr) |
AU (1) | AU2012276476B2 (fr) |
BR (1) | BR112013033475A2 (fr) |
CA (1) | CA2840521C (fr) |
EA (1) | EA029932B1 (fr) |
ES (1) | ES2668943T3 (fr) |
HK (1) | HK1193050A1 (fr) |
IL (1) | IL230174A (fr) |
MA (1) | MA35610B1 (fr) |
MX (1) | MX367663B (fr) |
MY (1) | MY167609A (fr) |
SG (1) | SG10201605314TA (fr) |
TN (1) | TN2013000526A1 (fr) |
UA (1) | UA112652C2 (fr) |
WO (1) | WO2013002578A2 (fr) |
ZA (1) | ZA201400653B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10045944B2 (en) | 2013-12-31 | 2018-08-14 | Ctc Bio, Inc. | Pharmaceutical composition containing clomipramine and preparation method therefor |
EP3646871A1 (fr) * | 2018-10-30 | 2020-05-06 | SEROJAC PME Handels GmbH | Traitement et prévention de l'éjaculation précoce (pe) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403597B1 (en) * | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
US6495154B1 (en) * | 2000-11-21 | 2002-12-17 | Vivus Inc. | On demand administration of clomipramine and salts thereof to treat premature ejaculation |
US20030229001A1 (en) * | 2002-01-31 | 2003-12-11 | Pfizer Inc. | Treatment of male sexual dysfunction |
WO2005025550A1 (fr) * | 2003-09-15 | 2005-03-24 | Vectura Limited | Compositions pharmaceutiques permettant de traiter l'ejaculation precoce par inhalation pulmonaire |
CA2613617A1 (fr) * | 2005-06-27 | 2007-01-04 | Daniel Drai | Compositions et methodes permettant d'ameliorer la fonction sexuelle |
US20070166344A1 (en) | 2006-01-18 | 2007-07-19 | Xin Qu | Non-leaching surface-active film compositions for microbial adhesion prevention |
EP2243360A4 (fr) | 2008-02-20 | 2011-06-01 | Daiwabo Holdings Co Ltd | Substance antivirale, fibre antivirale et structure de fibre antivirale |
WO2009142428A2 (fr) * | 2008-05-19 | 2009-11-26 | Yuhan Corporation | Composition pharmaceutique destinée au traitement de l'éjaculation précoce |
KR20110062620A (ko) | 2009-12-03 | 2011-06-10 | 유비벨록스(주) | 전자지갑디바이스를 이용한 금융 제휴서비스 제공시스템 및 이를 이용한 금융 제휴서비스제공방법 |
-
2011
- 2011-06-28 BR BR112013033475A patent/BR112013033475A2/pt not_active Application Discontinuation
-
2012
- 2012-06-28 MY MYPI2013004697A patent/MY167609A/en unknown
- 2012-06-28 ES ES12805397.2T patent/ES2668943T3/es active Active
- 2012-06-28 CA CA2840521A patent/CA2840521C/fr active Active
- 2012-06-28 EP EP12805397.2A patent/EP2727595B1/fr active Active
- 2012-06-28 WO PCT/KR2012/005134 patent/WO2013002578A2/fr active Application Filing
- 2012-06-28 US US14/129,705 patent/US20140200210A1/en not_active Abandoned
- 2012-06-28 MX MX2014000082A patent/MX367663B/es active IP Right Grant
- 2012-06-28 JP JP2014518801A patent/JP6042886B2/ja active Active
- 2012-06-28 EA EA201490173A patent/EA029932B1/ru not_active IP Right Cessation
- 2012-06-28 AU AU2012276476A patent/AU2012276476B2/en not_active Ceased
- 2012-06-28 CN CN201280032699.9A patent/CN103635194B/zh active Active
- 2012-06-28 KR KR1020137033119A patent/KR101978459B1/ko active IP Right Grant
- 2012-06-28 EP EP17205420.7A patent/EP3323416B1/fr active Active
- 2012-06-28 UA UAA201400780A patent/UA112652C2/uk unknown
- 2012-06-28 SG SG10201605314TA patent/SG10201605314TA/en unknown
-
2013
- 2013-12-23 TN TNP2013000526A patent/TN2013000526A1/fr unknown
- 2013-12-26 IL IL230174A patent/IL230174A/en active IP Right Grant
-
2014
- 2014-01-22 MA MA36706A patent/MA35610B1/fr unknown
- 2014-01-27 ZA ZA2014/00653A patent/ZA201400653B/en unknown
- 2014-07-03 HK HK14106698.6A patent/HK1193050A1/zh not_active IP Right Cessation
-
2019
- 2019-04-04 US US16/375,404 patent/US20190224208A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SG10201605314TA (en) | 2016-08-30 |
MY167609A (en) | 2018-09-20 |
US20140200210A1 (en) | 2014-07-17 |
EA029932B1 (ru) | 2018-05-31 |
WO2013002578A3 (fr) | 2013-04-11 |
WO2013002578A2 (fr) | 2013-01-03 |
CA2840521A1 (fr) | 2013-01-03 |
JP2014527513A (ja) | 2014-10-16 |
UA112652C2 (uk) | 2016-10-10 |
AU2012276476B2 (en) | 2017-06-29 |
IL230174A (en) | 2017-07-31 |
CN103635194B (zh) | 2016-02-10 |
KR20140043898A (ko) | 2014-04-11 |
AU2012276476A1 (en) | 2014-02-13 |
BR112013033475A2 (pt) | 2017-12-19 |
KR101978459B1 (ko) | 2019-05-14 |
CA2840521C (fr) | 2019-11-26 |
EP2727595A2 (fr) | 2014-05-07 |
ES2668943T3 (es) | 2018-05-23 |
MX367663B (es) | 2019-08-30 |
TN2013000526A1 (en) | 2015-03-30 |
US20190224208A1 (en) | 2019-07-25 |
JP6042886B2 (ja) | 2016-12-14 |
CN103635194A (zh) | 2014-03-12 |
ZA201400653B (en) | 2016-11-30 |
EP2727595A4 (fr) | 2015-03-04 |
MX2014000082A (es) | 2014-05-01 |
EP3323416A1 (fr) | 2018-05-23 |
EA201490173A1 (ru) | 2014-04-30 |
EP3323416B1 (fr) | 2020-04-22 |
EP2727595B1 (fr) | 2018-02-21 |
HK1193050A1 (zh) | 2014-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20141159A1 (es) | Metodos para tratar o prevenir trastornos relacionados con el colesterol | |
CL2015002412A1 (es) | Composición farmacéutica sólida de daptomicina; método de fabricación; y uso para tratar infecciones bacterianas (divisional de la sol. 1336-2012) | |
MA45598B1 (fr) | Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda | |
EA200802412A1 (ru) | Терапевтические комбинации для сопровождающихся болью медицинских состояний | |
MA32903B1 (fr) | Inhibiteurs de proteine-kinases | |
MA35070B1 (fr) | Traitements ophtalmiques | |
WO2011014255A8 (fr) | Traitement de la maladie de crohn au moyen de laquinimod | |
CL2007002705A1 (es) | Composicion farmaceutica oftalmica autopreservada que comprende 0,04 a 0,9 mm de iones zinc donde la concentracion de aniones tamponantes es menor que 15 mm. | |
BR112013003934A2 (pt) | depot de fosfolipídeos | |
CR20110115A (es) | Metodos para tratar la talasemia | |
MX2019000547A (es) | Formulaciones de adamts13 liquidas y liofilizadas, estabilizadas. | |
NZ597031A (en) | Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm) | |
EA200701751A1 (ru) | Улучшенные составы фенофибрата | |
MA33991B1 (fr) | Procede de traitement des troubles de l'angiogenese oculaire ou de la fuite vasculaire | |
MA31706B1 (fr) | Formulations galéniques de composés organiques | |
ATE481094T1 (de) | Behandlung von diabetischer nephropathie | |
GEP201706606B (en) | Water-in-oil type emulsion for treating a disease of the eye | |
CO6280474A2 (es) | Composicion farmaceutica para el tratamiento de la eyaculacion precoz | |
CL2012001636A1 (es) | Supositorio rectal de mesalamina , en donde las particulas de mesalamina tienen un area de superficie de 0,1 m2/g a 1,3 m2/g, util en el tratamiento de proctitis ulcerosa activa. | |
MA35610B1 (fr) | Composition pharmaceutique pour traiter l'éjaculation prématurée et procédé pour traiter l'éjaculation prématurée | |
MA33602B1 (fr) | Composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipide | |
MA37676A1 (fr) | Nouveau promédicament de rebamipide, son procédé de fabrication et son utilisation | |
LV13887A (lv) | Pretmikrobu līdzeklis | |
TN2010000108A1 (fr) | Traitement de symtomes vasomoteurs | |
RU2016147400A (ru) | Способ лечения катаракты и глазные капли для его осуществления |